Engineering nanoliposomes to enhance cancer immunotherapy by reversing immunosuppression and synergistically boosting tumour immunogenicity

The clinical success of immune checkpoint inhibitors (ICIs) has initiated a new era in the treatment of metastatic cancer. Unfortunately, the overall response rate of ICIs in pretreated metastatic breast cancer (BC) is generally less than 20% due to many challenges, including low immunogenicity and...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Chunmei Zhang, Yandi Tan, Ju Huang, Xinyi Tang, Hongwei Xiang, Bin Shen, Chenchen Tang, Rui Li
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2023-09-01
coleção:	Materials & Design
Assuntos:	Immune checkpoint inhibitors Lactate Immunosuppressive tumor microenvironment Sonodynamic therapy Immunogenic cell death
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S0264127523006172
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!